Diethelm A G, Sterling W A, Aldrete J S, Shaw J F, Morgan J M
Ann Surg. 1976 May;183(5):502-10. doi: 10.1097/00000658-197605000-00007.
One hundred consecutive patients receiving related donor kidneys were analyzed in regards to graft and patient survival, morbidity, mortality, histocompatibility and rehabilitation. The average followup was 3 years and 2 months with a minimum post transplant evaluation of one year. Donor morbidity was minimal and the mortality nil. Recipient mortality was 17%, all of which occurred after the first two post transplant months. The most serious life threatening complications after transplantation were due to infection. The greatest morbidity was secondary to aseptic necrosis. The overall graft survival at one year was 94%, 2 years--87%, 3 years--81% and 4 and 5 years--72%. Separation of patients according to tissue typing revealed 95% of recipients with A and B matched kidneys to be alive 5 years later compared to 55% of patients receiving C and D matched kidneys. Rehabilitation was good to excellent in 76% of the living patients and poor in only 4%. These results suggest related donor renal transplantation to be the treatment of choice for patients with chronic renal failure excluding only those individuals who are exceptionally high risks in terms of morbidity and mortality.
对100例接受亲属供肾的患者进行了移植肾和患者生存率、发病率、死亡率、组织相容性及康复情况的分析。平均随访时间为3年2个月,移植后最短评估时间为1年。供者发病率极低,死亡率为零。受者死亡率为17%,均发生在移植后的前两个月。移植后最严重的危及生命的并发症是感染。最大的发病率继发于无菌性坏死。移植肾1年总体生存率为94%,2年为87%,3年为81%,4年和5年为72%。根据组织配型对患者进行分组,结果显示,5年后,95%的A、B配型肾受者存活,而接受C、D配型肾的患者只有55%存活。76%的存活患者康复情况良好至极佳,只有4%较差。这些结果表明,亲属供肾肾移植是慢性肾衰竭患者的首选治疗方法,仅排除那些在发病率和死亡率方面风险极高的个体。